Ohcanbohtosat - Timo D. Müller

Aiddostahte ozu
  1. 1
    The molecular pharmacology of glucagon agonists in diabetes and obesity

    The molecular pharmacology of glucagon agonists in diabetes and obesity Dahkki Aaron Novikoff, Timo D. Müller

    Almmustuhtton 2023
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments

    (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments Dahkki Günter Müller, Timo D. Müller

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Antagonizing GIPR adds fire to the GLP-1R flame

    Antagonizing GIPR adds fire to the GLP-1R flame Dahkki Aaron Novikoff, Timo D. Müller

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Incretin hormones and type 2 diabetes

    Incretin hormones and type 2 diabetes Dahkki Michael A. Nauck, Timo D. Müller

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Therapeutic Potential of Targeting the Ghrelin Pathway

    Therapeutic Potential of Targeting the Ghrelin Pathway Dahkki Gustav Colldén, Matthias H. Tschöp, Timo D. Müller

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Ghrelin regulation of glucose metabolism

    Ghrelin regulation of glucose metabolism Dahkki Anne-Laure Poher, Matthias H. Tschöp, Timo D. Müller

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Gut hormone polyagonists for the treatment of type 2 diabetes

    Gut hormone polyagonists for the treatment of type 2 diabetes Dahkki Sara J. Brandt, A. Götz, Matthias H. Tschöp, Timo D. Müller

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes Dahkki Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, Timo D. Müller

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Anti-obesity drug discovery: advances and challenges

    Anti-obesity drug discovery: advances and challenges Dahkki Timo D. Müller, Matthias Blüher, Matthias H. Tschöp, Richard D. DiMarchi

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia

    Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia Dahkki Timo D. Müller, Diego Pérez–Tilve, Jenny Tong, Paul T. Pfluger, Matthias H. Tschöp

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Anti-Obesity Therapy: from Rainbow Pills to Polyagonists

    Anti-Obesity Therapy: from Rainbow Pills to Polyagonists Dahkki Timo D. Müller, Christoffer Clemmensen, Brian Finan, Richard D. DiMarchi, M. Tschöp

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Glucagon Regulation of Energy Expenditure

    Glucagon Regulation of Energy Expenditure Dahkki Maximilian Kleinert, Stephan Sachs, Kirk M. Habegger, Susanna M. Hofmann, Timo D. Müller

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology

    Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology Dahkki Sara J. Brandt, Timo D. Müller, Richard D. DiMarchi, M. Tschöp, Kerstin Stemmer

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Glucagon's Metabolic Action in Health and Disease

    Glucagon's Metabolic Action in Health and Disease Dahkki Anja Zeigerer, Revathi Sekar, Maximilian Kleinert, Shelly Nason, Kirk M. Habegger, Timo D. Müller

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Gut-Brain Cross-Talk in Metabolic Control

    Gut-Brain Cross-Talk in Metabolic Control Dahkki Christoffer Clemmensen, Timo D. Müller, Stephen C. Woods, Hans-Rudolf Berthoud, Randy J. Seeley, Matthias H. Tschöp

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    GLP-1/glucagon receptor co-agonism for treatment of obesity

    GLP-1/glucagon receptor co-agonism for treatment of obesity Dahkki Miguel A. Sánchez-Garrido, Sara J. Brandt, Christoffer Clemmensen, Timo D. Müller, Richard D. DiMarchi, Matthias H. Tschöp

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications

    GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications Dahkki Jonathan E. Campbell, Timo D. Müller, Brian Finan, Richard D. DiMarchi, Matthias H. Tschöp, David A. D’Alessio

    Almmustuhtton 2023
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Unimolecular Polypharmacy for Treatment of Diabetes and Obesity

    Unimolecular Polypharmacy for Treatment of Diabetes and Obesity Dahkki Matthias H. Tschöp, Brian Finan, Christoffer Clemmensen, Vasily M. Gelfanov, Diego Pérez–Tilve, Timo D. Müller, Richard D. DiMarchi

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

    Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes Dahkki Qiming Tan, Seun Akindehin, Camila E. Orsso, Richelle C. Waldner, Richard D. DiMarchi, Timo D. Müller, Andrea M. Haqq

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    'Fat mass and obesity associated' gene (FTO): No significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents

    'Fat mass and obesity associated' gene (FTO): No significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German ob... Dahkki Timo D. Müller, Anke Hinney, André Scherag, Thuy Trang Nguyen, Felix Schreiner, H. Schäfer, Johannes Hebebrand, Christian L. Roth, Thomas Reinehr

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: